GlassScriptPhysician profile
Andre R Gazdag
NPI 1497750616
$6,601.59
in general payments reported to CMS, 2019-2025
9 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.11 · 2021: $3,603 · 2022: $2,376 · 2023: $241 · 2024: $181 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $3,415.55 | 2021-2022 | |
| Arthrex, INC. | $2,589.36 | 2021-2023 | Distal Extremities Implants Foot & Ankle Dynanite Staples |
| Medline Industries LP | $142.87 | 2024 | |
| Smith+Nephew, INC. | $141.81 | 2024-2025 | Grafix, Stravix, Bone Anchors With Arthroscopic Delivery System |
| Linvatec Corporation | $109.81 | 2023 | Allograft Tissue |
| Zimmer Biomet Holdings, INC. | $97.11 | 2019 | |
| Depuy Synthes Sales INC. | $42.30 | 2022 | |
| Ossio INC | $37.00 | 2022 | |
| Siemens Medical Solutions USA, INC. | $25.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Gazdag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.